IDH Integrated Diagnostics Holdings

IDH Integrated Diagnostics Holdings, publicly traded as LON: IDHC, is a prominent consumer healthcare company established in 1979, specializing in diagnostic services across the Middle East and Africa. The company operates a significant network of diagnostic laboratories and medical testing facilities, leveraging established brands such as Al Borg, Al Mokhtabar, Biolab, Ultralab, and Echo-Scan. With a commitment to quality and safety, IDH offers over 1,400 distinct diagnostic tests, many holding international accreditations. Its strategic Hub, Spoke, and Spike business model facilitates regional expansion, combining centralized testing capabilities with a distributed network of collection centers to serve diverse markets effectively.

The company employs between 5,000 and 10,000 individuals, supporting its extensive operations across Egypt, Jordan, Sudan, and Nigeria. IDH provides comprehensive healthcare solutions catering to both business-to-business (B2B) and business-to-consumer (B2C) segments. Customer convenience is enhanced through integrated mobile applications and dedicated call centers, ensuring accessibility and efficient service delivery. For insights into the people driving these operations, one can Meet IDH Integrated Diagnostics Holdings's team.

IDH's revenue reached $121.1M, underscoring its substantial market presence and financial scale. The company's operational footprint is designed for scalability, enabling it to adapt to evolving healthcare demands within its target regions. By focusing on high-quality medical diagnostic services, IDH plays a critical role in the healthcare ecosystem, providing essential testing and laboratory solutions to a broad customer base. Its continued expansion reflects a robust strategy for growth within the dynamic African and Middle Eastern healthcare sectors.